Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Marksans Pharma Ltd
BSE:524404
Marksans Pharma Ltd
BSE:524404
Price:
342.8
INR
3.38%
Market Closed
Market Cap:
₹155.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Marksans Pharma Ltd
BSE:524404
|
IN |
|
Persimmon PLC
F:OHP0
|
UK |
|
E
|
Exelon Corp
F:PEO
|
US |
|
F
|
Factset Research Systems Inc
SWB:FA1
|
US |
|
K
|
Kilroy Realty Corp
F:KRC
|
US |
|
F
|
Fujitsu Ltd
XHAN:FUJ1
|
JP |
|
2
|
29Metals Ltd
ASX:29M
|
AU |
|
A
|
Align Technology Inc
SWB:AFW
|
US |
Wall St Price Targets
MARKSANS Price Forecast
Based on 3 analysts
Based on 3 analysts
-13% Downside
from
₹342.8
today
Marksans Pharma Ltd (524404)’s 12-month stock price forecast through September 2027 has a consensus target of ₹299.52, implying 13% downside. The forecast is based on price targets from 3 Wall Street analysts.
MARKSANS Analyst Rating
No ratings yet
No ratings yet
Marksans Pharma Ltd Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MARKSANS's stock price target?
Price Target
299.52
INR
299.52
INR
According to Wall Street analysts, the average 1-year price target for MARKSANS is 299.52 INR with a low forecast of 211.84 INR and a high forecast of 396.42 INR.
What is the Revenue forecast for Marksans Pharma Ltd?
Projected CAGR
16%
16%
Over the last 13 years, the compound annual growth rate for Revenue has been 16%. The projected CAGR for the next 3 years is 16%.
What is the Gross Profit forecast for Marksans Pharma Ltd?
Projected CAGR
22%
22%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 18%. The projected CAGR for the next -11 years is 22%.
What is the Operating Income forecast for Marksans Pharma Ltd?
Projected CAGR
28%
28%
Over the last 13 years, the compound annual growth rate for Operating Income has been 19%. The projected CAGR for the next 3 years is 28%.
What is the Pre-Tax Income forecast for Marksans Pharma Ltd?
Projected CAGR
22%
22%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 22%. The projected CAGR for the next 2 years is 22%.
What is the Net Income forecast for Marksans Pharma Ltd?
Projected CAGR
23%
23%
Over the last 13 years, the compound annual growth rate for Net Income has been 19%. The projected CAGR for the next 3 years is 23%.